Ligand–Copper & Iron–O₂ Reactivity: Comprehensive Bullet-Note Summary

Copper–O₂ Systems: Formation & Inter-Conversion of Reactive Intermediates

  • Redox sequence after O₂ binding to Cu(I)–L (L = N/O/S donor, bidentate–tetradentate)

    • Cu(I)–L+O<em>2Cu(II)–O</em>2!\text{Cu(I)–L} + \text{O}<em>2 \rightarrow \text{Cu(II)}–\text{O}</em>2^{!*−}
    • End-on superoxo ⇆ side-on superoxo (ligand denticity & pocket size govern geometry).
    • Proton/electron delivery → hydroperoxo: Cu(II)–O2!+H++eCu(II)–OOH\text{Cu(II)}–\text{O}_2^{!*−}+\text{H}^+ + e^- \rightarrow \text{Cu(II)}–\text{OOH}
    • Second Cu(I) equivalent yields dinuclear complexes:
    • End-on µ-η¹:η¹ peroxo with tetradentate ligands.
    • Side-on µ-η²:η² peroxo with tridentate ligands.
    • Further O–O cleavage ⇒ bis(µ-oxo) Cu(III)<em>2(μ-O)</em>2\text{Cu(III)}<em>2(\mu\text{-O})</em>2 (high-valent “cupryl”).
    • Entire manifold is in rapid equilibrium; subtle changes in donor type (aliphatic vs aromatic, N vs O/S) shift speciation.
  • Reactivity profile

    • Superoxo = H-atom abstractor (nucleophilic character toward weak X–H).
    • Peroxo/hydroperoxo = electrophilic oxidants (O-atom transfer, C–C/N cleavage).
    • Synthetic models reproduce PHM/DBM chemistry: selective H-atom abstraction leading to N-dealkylation, substrate hydroxylation.
  • Spectroscopic handles

    • UV-vis signatures: superoxo (~350–450 nm), peroxo (550–600 nm), bis-µ-oxo (~350 nm shoulder).
    • Resonance Raman (ν<em>O–O\nu<em>{\text{O–O}} shifts on 18O</em>2^{18}\text{O}</em>2), rapid-freeze/stop-flow capture (sub-second timescale).

Copper vs Iron: Analogous High-Valent Pathways

  • Formal homolysis of Cu(II)–OOH\text{Cu(II)}–\text{OOH} affords postulated cupryl Cu(III)!=!O\text{Cu(III)}!=!O (or Cu(II)–O\text{Cu(II)}–O^\bullet) analogous to Fe(IV)=O\text{Fe(IV)}=O in heme enzymes.
  • Debate: in PHM/DBM active species could be superoxo, hydroperoxo, cupryl, or bis-µ-oxo; lack of crystallographic capture keeps discussion open.

Heme–Copper Oxidases (HCO / Cytochrome c Oxidase)

  • Active site: heme-a₃ (Fe) + Cu_B (3His, Tyr-His cross-link).
  • Catalytic cycle
    1. Fe2+\text{Fe}^{2+} + O₂ → Fe3+O2!\text{Fe}^{3+}–O_2^{!*−} (pulled into porphyrin plane).
    2. Electron from Cu+\text{Cu}^{+} → µ-peroxo Fe3+O22Cu2+\text{Fe}^{3+}–O_2^{2−}–\text{Cu}^{2+}.
    3. Proton/electron steps cleave O–O → water, generating transient Fe4+=O\text{Fe}^{4+}=O / Cu2+OH\text{Cu}^{2+}–OH with Tyr•.
  • Synthetic side-on/side-on and side-on/end-on Fe–Cu peroxos characterized; protonation triggers O–O scission to Fe4+=O\text{Fe}^{4+}=O.

Heme Systems Without Copper

Cytochrome P450 (thiolate-ligated)

  • Resting Fe3+\text{Fe}^{3+} → O₂ adduct → peroxo Fe3+O22\text{Fe}^{3+}–O_2^{2−}.
  • Protonations → hydroperoxo (“Compound 0”) → heterolysis ⇒ Compound I \text{Fe}^{4+}=O\;\text{Porphyrin•^+} (formal Fe5+=O\text{Fe}^{5+}=O).
  • Compound I abstracts H•, then “rebound” gives R!!OHR!−!OH (aliphatic) or installs heteroatoms.

Peroxidases & Catalases

  • Use H₂O₂ as oxidant (“peroxide shunt”), generating Compound I; peroxidases oxidize substrates, catalase disproportionates 2 H₂O₂ → 2 H₂O + O₂.

Non-Heme Fe Oxygenases

General Motifs

  • Fe(II) coordinated by “2-His-1-carboxylate” facial triad.
  • O₂ activation produces Fe(IV)=O\text{Fe(IV)}=O or di-Fe bis-µ-oxo species depending on system.

α-Ketoglutarate (α-KG)-Dependent Family

  • Cosubstrate α-KG binds bidentate; O₂ attack at keto carbon forms alkyl-peroxo; decarboxylation → Fe(IV)=O\text{Fe(IV)}=O + succinate.
  • Fe(IV)=O\text{Fe(IV)}=O abstracts H•; rebound gives hydroxylation (oxygenase) or, if Asp/Glu in triad is replaced by Cl⁻/Br⁻, halogen rebound dominates (halogenase).

Non-Heme Model Chemistry

  • Fe(III)–OOH → O–O cleavage (assisted by H₂O or RCO₂H) → Fe(V)=O(OH)\text{Fe(V)}=O(OH).
  • Predictable C–H selectivity: 3°>2°>1°; electron-withdrawing substituents or sterics invert/prevent reaction; carboxylate directing overrides innate bias.

Methane Monooxygenase (sMMO, di-Fe)

  • Resting Fe(II)₂ → O₂ → µ-η¹:η¹ superoxo Fe(III)–O2!<em>–Fe(II)\text{Fe(III)}–O_2^{!<em>−}–\text{Fe(II)} (P).
  • Electron/proton steps → peroxo (P) Fe(III)<em>2!(μ!!O</em>22)\text{Fe(III)}<em>2!(\mu!−!O</em>2^{2−}).
  • O–O cleavage → Q (bis-µ-oxo Fe(IV)<em>2(μ!!O)</em>2\text{Fe(IV)}<em>2(\mu!−!O)</em>2, 720 nm band).
  • Q + CH₄ (k ≈ 104  M1s110^4\;\text{M}^{−1}\text{s}^{−1}) → CH₃OH + Fe(III)<em>2(μ!!OH)</em>2\text{Fe(III)}<em>2(\mu!−!OH)</em>2.
  • Kinetic isotope effect large for “class I” substrates (C–H activation RDS); for bigger substrates diffusion to active site becomes rate-limiting.

Photosystem II Oxygen-Evolving Complex (OEC)

  • Inorganic core: Mn<em>4CaO</em>5\text{Mn}<em>4\text{CaO}</em>5 (questioned due to X-ray damage).
  • Kok cycle S₀–S₄: sequential oxidation by Tyr_Z•; S₄ → O–O bond formation, release of O₂, reset to S₀.
  • Leading model: Mn(V)=O attacked by Ca–OH nucleophile yielding peroxo; alternatives consider µ-oxo coupling.
  • Experimental probes: EPR multiline (S₂), X-ray emission, X-ray free-electron laser snapshots to minimize radiation reduction.

Cross-Cutting Themes & Exam Tips

  • Superoxo (one-electron reduced O₂) is generally a radical H-atom abstractor.

  • Peroxo/hydroperoxo (two-electron reduced) are electrophilic; protonation state tunes activity.

  • High-valent M═O / M–O• (Cu or Fe) perform the scission of strong C–H (up to \sim105\;\text{kcal·mol}^{−1} for CH₄).

  • Axial ligand charge modulates Fe–O bond: thiolate (P450) pushes e⁻ density, easing O–O cleavage and stabilizing Compound I.

  • Facial triad swap (Asp/Glu ↔ Cl⁻) diverts α-KG enzymes from hydroxylation to halogenation.

  • Spectroscopy cheat-sheet:

    • Fe(IV)=O\text{Fe(IV)}=O (heme) → near-IR & Mossbauer δ0.0\delta\approx0.0 mm s⁻¹.
    • Fe(IV)<em>2(μ!!O)</em>2\text{Fe(IV)}<em>2(\mu!−!O)</em>2 Q → 720 nm UV-vis.
    • Cu(II)–O<em>2!\text{Cu(II)}–O<em>2^{!*−} end-on ν</em>O–O\nu</em>{\text{O–O}} ≈ 1120–1140 cm⁻¹.
  • Remember key stoichiometries in LaTeX:

    • HCO overall: 4Cu+/Fe2++O<em>2+8H+4Cu2+/Fe3++2H</em>2O4\,\text{Cu}^{+}/\text{Fe}^{2+}+\text{O}<em>2+8\,\text{H}^+ \rightarrow 4\,\text{Cu}^{2+}/\text{Fe}^{3+}+2\,\text{H}</em>2\text{O}.
    • P450 monooxygenation: RH+O<em>2+NADPH+H+ROH+H</em>2O+NADP+\text{RH}+\text{O}<em>2+\text{NADPH}+\text{H}^+ \rightarrow \text{ROH}+\text{H}</em>2\text{O}+\text{NADP}^+.
    • sMMO: CH<em>4+O</em>2+2H++2eCH<em>3OH+H</em>2O\text{CH}<em>4+\text{O}</em>2+2\,\text{H}^++2e^- \rightarrow \text{CH}<em>3\text{OH}+\text{H}</em>2\text{O}.
    • OEC net (per cycle): 2H<em>2O4hνO</em>2+4H++4e2\,\text{H}<em>2\text{O} \xrightarrow{4\,h\nu} \text{O}</em>2+4\,\text{H}^++4e^-.

Study Strategy

  • Map each enzyme to: (i) metal site architecture, (ii) sequence of O₂-derived intermediates, (iii) principal oxidative step.
  • Correlate synthetic models to biological analogues to rationalize reactivity trends.
  • Practice electron-counting and formal charge assignments; convert M=OM=OMn1OM^{n-1}–O^• representations fluently.
  • Use provided UV-vis/Resonance Raman bands as fingerprint identifiers in mechanism problems.